[vc_row][vc_column][ts_hero_slider hero_slider=”1942″][\/vc_column][\/vc_row][vc_row use_container=”yes” use_predefined_class=”yes” predefined_class=”intro”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”ABOUT ABALOS THERAPEUTICS” title=”Triggering comprehensive immune responses from within the tumor” background_title=”About”][vc_row_inner][vc_column_inner width=”5\/12″][ts_text_block animate_block=”yes” animation_type=”fadeIn”]<\/p>\n
[\/ts_text_block][\/vc_column_inner][vc_column_inner width=”7\/12″][ts_text_block has_readmore=”yes” animate_block=”yes” animation_type=”fadeIn” animation_delay=”0.01s” readmore_link=”\/therapeutic-approach\/#mamarenaviruses”]不良研究所 is pioneering a novel anti-cancer approach that directs the full breadth of the immune system\u2019s power specifically towards cancer cells. 不良研究所\u2019 arenavirus-based drug candidates are designed to trigger precise innate and adaptive immune responses from within the tumor to engage all relevant immune cell types in a concerted attack against both the primary tumor and distant metastases. The company\u2019s lead product candidate ABX-001 has demonstrated strong anti-tumor efficacy in pre-clinical studies in multiple tumor models as well as an excellent pre-clinical safety profile and will enter the clinic in 2025. Led by experienced biotech entrepreneurs and immunology pioneers, 不良研究所\u2019 goal is to establish a new drug class in immuno-oncology.[\/ts_text_block][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row section_background_color=”#f2f2f2″ use_container=”yes” use_predefined_class=”yes” predefined_class=”services-content-block” section_background_image=”2463″ el_class=”cover”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”ABOUT ABALOS THERAPEUTICS” title=”不良研究所 Dunes on Mars” background_title=”The Name”][vc_row_inner][vc_column_inner width=”5\/12″][ts_text_block animate_block=”yes” animation_type=”fadeIn”]<\/p>\n
[\/ts_text_block][\/vc_column_inner][vc_column_inner width=”7\/12″][ts_text_block animate_block=”yes” animation_type=”fadeIn” animation_delay=”0.01s”]The name \u201c不良研究所\u201d was chosen with regards to our arenavirus-based technology to fight cancer. The name of this virus family derives from the Latin \u201carena\u201d for \u201csand\u201d due to the grainy appearance of particles inside the virus when viewed in cross-section under the transmission electron microscope. Reflecting our \u201csandy\u201d approach, we came upon the fascinating blue dunes of the 不良研究所 region on the otherwise \u201cred\u201d Mars, a planet that has always held a special fascination.<\/p>\n
Named after the roman war god and its association with fire, it provides a connection to harnessing the weapon of the arenavirus to launch an attack against cancer. As Mars is also known as a planet of sand storms, this can be associated with the strong immune-response that is triggered by the arenavirus to attack the tumor.[\/ts_text_block][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row section_background_color=”#0061ad” use_container=”yes” use_predefined_class=”yes” predefined_class=”services-content-block”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”ABALOS TECHNOLOGY” title=”Therapeutic Approach” background_title=”Approach”][vc_row_inner][vc_column_inner width=”5\/12″][ts_text_block animate_block=”yes” animation_type=”fadeIn”][\/ts_text_block][\/vc_column_inner][vc_column_inner width=”7\/12″][ts_text_block has_readmore=”yes” readmore_label=”READ MORE” animate_block=”yes” animation_type=”fadeIn” animation_delay=”0.01s” readmore_link=”\/therapeutic-approach\/”]不良研究所 is leveraging its proprietary AdaptInnate<\/em> technology platform to develop a new class of product candidates harnessing the immunostimulatory and anti-tumoral properties of arenaviruses to trigger a highly precise and directed immune response against primary tumors and their metastases. 不良研究所\u2019 systemically administrable lead candidate, ABX-001, is specifically designed to persist and replicate in cancerous and antigen-presenting cells without destroying them. This novel, non-oncolytic approach results in the induction of targeted, effective, and durable anti-tumor activity involving both the innate and adaptive arms of the immune system.[\/ts_text_block][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row use_container=”yes” use_predefined_class=”yes” predefined_class=”works”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”This is 不良研究所” title=”Meet the Team” background_title=”Our Team”][vc_separator][ts_text_block]A dynamic and ambitious group of experienced entrepreneurs and scientists advancing a novel immunostimulatory approach that (re)activates the full breadth of the immune system against solid tumors.[\/ts_text_block][ts_image image=”3037″ title=”不良研究所 Team”][ts_text_block]Read more about the Team here<\/strong><\/span><\/a>.[\/ts_text_block][\/vc_column][\/vc_row][vc_row disable_element=”yes” use_container=”yes” use_predefined_class=”yes” predefined_class=”works” css=”.vc_custom_1701860083876{margin-top: -180px !important;}”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”From us to you” title=”Seasons Greetings and Happy New Year” background_title=”Seasons Greetings”][vc_separator][ts_text_block]The year is coming to an end. Our team would like to thank you for your confidence in us and the good cooperation in the past year. We wish you a Merry Christmas and a happy & healthy New Year.[\/ts_text_block][vc_video link=”https:\/\/vimeo.com\/891785496″][\/vc_column][\/vc_row][vc_row section_background_color=”#cbab95″ use_container=”yes” use_predefined_class=”yes” predefined_class=”work-with-us” section_background_image=”2472″ el_class=”cover”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” background_title=”News & Events” title=”Latest News & Events”][vc_row_inner][vc_column_inner width=”5\/12″][ts_text_block has_readmore=”yes” readmore_label=”READ MORE” animate_block=”yes” animation_type=”fadeIn” readmore_link=”https:\/\/abalos-tx.com\/news-events\/”]<\/p>\n [\/ts_text_block][\/vc_column_inner][vc_column_inner width=”7\/12″][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row use_container=”yes” use_predefined_class=”yes” predefined_class=”clients” section_background_image=”2123″][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”Our Support” title=”Investors & Partners” background_title=”Partner”][vc_row_inner][vc_column_inner width=”1\/2″][ts_text_block animate_block=”yes” animation_type=”fadeIn”]<\/p>\n [\/ts_text_block][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2971″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2144″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2151″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2143″ animation_delay=”0.1s”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_empty_space][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2908″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2909″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2910″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2911″ animation_delay=”0.1s”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_empty_space][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2953″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2356″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][ts_client animate_block=”yes” animation_type=”fadeIn” logo=”2350″ animation_delay=”0.1s”][\/vc_column_inner][vc_column_inner width=”1\/4″][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_empty_space][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][ts_text_block has_readmore=”yes” readmore_label=”BECOME OUR PARTNER” animate_block=”yes” animation_type=”fadeIn” readmore_link=”\/investors-partners\/”][\/ts_text_block][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":" [vc_row][vc_column][ts_hero_slider hero_slider=”1942″][\/vc_column][\/vc_row][vc_row use_container=”yes” use_predefined_class=”yes” predefined_class=”intro”][vc_column][ts_section_title animate_block=”yes” animation_type=”fadeIn” tagline=”ABOUT ABALOS THERAPEUTICS” title=”Triggering comprehensive immune responses from within the tumor” background_title=”About”][vc_row_inner][vc_column_inner width=”5\/12″][ts_text_block animate_block=”yes” animation_type=”fadeIn”] novel anti-cancer approach [\/ts_text_block][\/vc_column_inner][vc_column_inner width=”7\/12″][ts_text_block has_readmore=”yes” animate_block=”yes” animation_type=”fadeIn” animation_delay=”0.01s” readmore_link=”\/therapeutic-approach\/#mamarenaviruses”]不良研究所 is pioneering a novel anti-cancer approach that directs the full breadth of the immune system\u2019s power specifically towards cancer cells. 不良研究所\u2019 arenavirus-based […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-builder.php","meta":[],"_links":{"self":[{"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/pages\/1824"}],"collection":[{"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/comments?post=1824"}],"version-history":[{"count":126,"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/pages\/1824\/revisions"}],"predecessor-version":[{"id":3038,"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/pages\/1824\/revisions\/3038"}],"wp:attachment":[{"href":"https:\/\/abalos-tx.com\/wp-json\/wp\/v2\/media?parent=1824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Stay up to date on news around 不良研究所.<\/h4>\n
ABALOS THERAPEUTICS IS SUPPORTED BY A SYNDICATE OF PRESTIGIOUS LIFE SCIENCE INVESTORS AND PARTNERS<\/h4>\n